CV
Education
- Ph.D in Pharmacology, Istanbul University, Faculty of Pharmacy, 2024
- M.S. in Pharmacology, Istanbul University, Faculty of Pharmacy, 1997
- M.S. in Pharmacy, Istanbul University, Faculty of Pharmacy, 1994
Professional Experience
- Pharmacist, Yiğit Pharmacy, 2004 - 2023
- Checking and processing prescriptions
- Consulting with patients about appropriate dosage and usage of medication, drug interactions, disease management and side effects of medications
- Managing the inventory of all products in stocks
- Product Manager, Nobel Pharmaceuticals, 1997 - 2003
- Preparing strategic marketing plans and marketing tools for products (Tylol Hot, Tylol, Funit)
- Developing core positioning and messaging for products.
- Performing sales, trend, and profitability analysis
- Educating sales team
- Developing relationships with opinion leader
- Licensing Assistant Specialist, Embil Pharmaceutical Company, 1996 - 1996
- Preparing and furthering license files for new drugs
- Developing relationships with Ministry of Health
Research Experience
- Research Assistant, Istanbul University, Faculty of Pharmacy, Pharmacology
- Ph.D. Research, Supervisor: F. Ilkay Alp Yıldırım
- Mechanisms responsible for cardioprotective effects of antidiabetics
- Chronic Inflammation, Inflammasomes
- Cellular Senescence
- MS Research, Supervisor: Ahmet C. Ekinci
- Learning and Memory
- Epilepsy
- Ph.D. Research, Supervisor: F. Ilkay Alp Yıldırım
Teaching Experience
Skills
- Technical: Isolated Organ Bath Method, Molecular Biology (PCR, Western Blot, Elisa)
- Computer: Microsoft Word, Excel, PowerPoint, GraphPad
- Language: English (fluent), Turkish (native)
Professional Affiliations
- Istanbul Chamber of Pharmacists
- Istanbul Chamber of Pharmacists Academy, Continuing Education Program (MISEP) Commission
- Turkish Pharmacological Society
Seminars and Courses Attended
- Training Program for Certificate of Animal Use in Experimental Studies, İstanbul University Aziz Sancar Institute of Experimental Medicine, 2017
- Theoretical and Practical Tissue Engineering Summer School, Hacettepe University, 2017
- Course on Technics Used in Molecular Medicine, 2017
- Mid-Management Grid, EKSER, 2001
- Marketing in the Pharmaceutical Industry, Fed Training, 2000
- Presentations Techniques, EKSER, 2000
- General and Business English, Kings College Bournemouth, 1999
Funding
- Istanbul University Scientific Research Procects Fund (Researcher)
- 210.000,00 TL, 2022 - 2024
- Evaluation of the Role of NLRP3 Inflammasome and Senescence in the Pleiotropic Effects of the SGLT-2 Inhibitor Dapagliflozin on the Vascular System
- TUBITAK Short Term R&D Funding Program (Principal Investigator)
- 45.000,00 TL, 2023 - 2024
- Evaluation of the Role of NLRP3 Inflammasome and Senescence in the Pleiotropic Effects of the SGLT-2 Inhibitor Dapagliflozin on the Vascular System
Publications
Sodium Glucose Co-Transporter 2 Inhibitors
Vidin Şen A, Alp Yıldırım Fİ. Sodyum glukoz ko-transporter 2 inhibitörleri. Kerry Z, Yağdı T, editörler. Kalp Yetersizliği ve Tedavisinde Yeni Hedefler. 1. Baskı. Ankara: Türkiye Klinikleri; 2023. p.141-6.
Anticonvulsant activity of some substituted 1,3,4-thiadiazoles
Gülerman, N.N.; Rollas, S.; Ekinci, A.C.; Vidin, A. Anticonvulsant activity of some substituted 1,3,4-thiadiazoles, Acta Pharmaceutica Turcica (2001)
Synthesis, characterization and pharmacological properties of some 4-arylhydrazono-2-pyrazoline-5-one derivatives obtained from heterocyclic amines
Güniz Küçükgüzel S, Rollas S, Erdeniz H, Kiraz M, Cevdet Ekinci A, Vidin A. Synthesis, characterization and pharmacological properties of some 4-arylhydrazono-2-pyrazoline-5-one derivatives obtained from heterocyclic amines. Eur J Med Chem. 2000 Jul-Aug;35(7-8):761-71. doi: 10.1016/s0223-5234(00)90179-x. PMID: 10960193.
Synthesis, Characterization and Anticonvulsant Activity of New 4-thiazolidinone and 1,2,4-triazole- 3-thione Derivatives
N. Ulusoy, G. Capan, N. Ergenc, A.C. Ekinci, A. Vidin, Synthesis, characterization and anticonvulsant activity of new 4- thiazolidinone and 1,2,4-triazole-3-thione derivatives, Acta Pharmaceutica Turcica. 40 (1998) 5–8.
Synthesis and antibacterial activity of 5-aryl-2- [(α-chloro-α-phenylacetyl/α- bromopropionyl)amino]-1,3,4-oxadiazoles and 2-[(5-aryl-1 ,3,4-oxadiazol-2-yl)imino]-5-phenyl/methyl-4-thiazolidinones
Ateş, Ö., Kocabalkanlı, A., Saniş, G. Ö., Ekinci, A. C., & Vidin, A. (1997). Synthesis and antibacterial activity of 5-aryl-2- [(?-chloro-?-phenylacetyl/?- bromopropionyl)amino]-1,3,4-oxadiazoles and 2-[(5-aryl-1 ,3,4-oxadiazol-2-yl)imino]-5-phenyl/methyl-4-thiazolidinones. Arzneimittel-Forschung/Drug Research, 47(10), 1134–1138.
Evaluation of antimycobacterial and anticonvulsant activities of new 1-(4-fluorobenzoyl)-4-substituted-thiosemicarbazide and 5-(4-fluorophenyl)-4-substituted-2,4-dihydro-3H-1,2,4-triazole-3-thione derivatives
Gülerman N, Rollas S, Kiraz M, Ekinci AC, Vidin A. Evaluation of antimycobacterial and anticonvulsant activities of new 1-(4-fluorobenzoyl)-4-substituted-thiosemicarbazide and 5-(4-fluorophenyl)-4-substituted-2,4-dihydro-3H-1,2,4-triazole-3-thione derivatives. Farmaco. 1997 Nov;52(11):691-5. PMID: 9550096.
Synthesis and anticonvulsant activity of new 3-[(2-furyl)carbonyl]amino-4-thiazolidinone and 2-[(2-furyl)carbonyl]hydrazono-4-thiazoline derivatives
Capan G, Ulusoy N, Ergenç N, Cevdet Ekinci A, Vidin A. Synthesis and anticonvulsant activity of new 3-[(2-furyl)carbonyl]amino-4-thiazolidinone and 2-[(2-furyl)carbonyl]hydrazono-4-thiazoline derivatives. Farmaco. 1996 Nov;51(11):729-32. PMID: 9035380.
Talks
Effects Of Dapagliflozin On Vascular Reactivity Of Internal Mammary Artery And Saphenous Vein Bypass Grafts Isolated From Diabetic And Nondiabetic Patients
at 2nd International and 27th National Pharmacology Congress, Antalya, Turkey
The Ability of Pharmacy Students to Recognise Clinically Important Drug Interactions
at 3rd National Clinical Pharmacy and Pharmaceutical Care Congress, Antalya, Turkey
